Trinity Biotech secures orders for 2 million tests
Trinity Biotech (NASDAQ:TRIB) secured new purchase orders for over 2 million HIV tests to support its annual financial objectives.
Trinity Biotech (NASDAQ:TRIB) secured new purchase orders for over 2 million HIV tests to support its annual financial objectives.
Zai Lab (NASDAQ:ZLAB) has received European orphan drug designation for its antibody-drug conjugate targeting 375,000 annual lung cancer cases.
Nebius (NASDAQ:NBIS) completed its corporate acquisition of model optimization developer Eigen AI on June 10, 2026.
Vince Holding (NASDAQ:VNCE) reported a 10.5% increase in first-quarter net sales to $64 million, driven by expansion across its direct-to-consumer and wholesale segments.
Edgewise Therapeutics (NASDAQ:EWTX) reported positive 12-week Phase 2 data evaluating its investigational heart disease treatment called EDG-7500.
Invivyd (NASDAQ:IVVD) completed enrollment in its Phase 3 LIBERTY trial to evaluate a potential COVID-19 prevention option.
Robinhood Markets (NASDAQ:HOOD) announced a 10% workforce reduction to maintain its long-term corporate agility and efficiency.
Prestige Consumer Healthcare (NYSE:PBH) closed its acquisition of the Breathe Right brand for $1.045 billion.
Parsons (NYSE:PSN) secured design and construction oversight contracts for the estimated $1.1–$1.4 billion John A. Blatnik Bridge replacement project.
InterDigital (NASDAQ:IDCC) secured a patent infringement injunction against Disney (NYSE:DIS) across 11 European Union countries for its video technology.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas